Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
The EMBO Journal
|
May 4, 2017
Programmed mitophagy is essential for the glycolytic switch during cell differentiation
Lorena Esteban-Martínez, Elena Sierra-Filardi, Rebecca S McGreal, et al.
Cell Death and Differentiation
|
December 13, 2017
Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer
Mónica Álvarez-Fernández, María Sanz-Flores, Belén Sanz-Castillo, et al.
Nature Cell Biology
|
September 1, 2015
AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest
Elena Doménech, Carolina Maestre, Lorena Esteban-Martínez, et al.
The EMBO Journal
|
November 3, 2022
Mammalian CDC14 phosphatases control exit from stemness in pluripotent cells
Carolina Villarroya-Beltri, Ana Filipa B Martins, Alejandro García, et al.
Oncogene
|
February 12, 2019
Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma
Irene Vázquez-Domínguez, Laura González-Sánchez, Pilar López-Nieva, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
Transient CB2 receptor activation triggers irreversible luminal differentiation via chromatin remodeling in breast cancer
Nuria G Martínez-Illescas, Gemma Pérez-García, María Rubert-Hernández, et al.
Breast Cancer Research : BCR
|
August 4, 2023
miR-203 drives breast cancer cell differentiation
Nuria G Martínez-Illescas, Silvia Leal, Patricia González, et al.
The EMBO Journal
|
July 3, 2020
Transient exposure to miR-203 enhances the differentiation capacity of established pluripotent stem cells
María Salazar-Roa, Marianna Trakala, Mónica Álvarez-Fernández, et al.
Autophagy
|
September 17, 2016
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
Sonia Hernández-Tiedra, Gemma Fabriàs, David Dávila, et al.
Oncogene
|
May 11, 2026
Cannabinoid CB<sub>2</sub> receptor drives trastuzumab resistance and predicts durable anti-HER2 response
Marta Seijo-Vila, Sofía A Balsinde, Sandra Blasco-Benito, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
The EMBO Journal
|
May 4, 2017
Programmed mitophagy is essential for the glycolytic switch during cell differentiation
Lorena Esteban-Martínez, Elena Sierra-Filardi, Rebecca S McGreal, et al.
Cell Death and Differentiation
|
December 13, 2017
Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer
Mónica Álvarez-Fernández, María Sanz-Flores, Belén Sanz-Castillo, et al.
Nature Cell Biology
|
September 1, 2015
AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest
Elena Doménech, Carolina Maestre, Lorena Esteban-Martínez, et al.
The EMBO Journal
|
November 3, 2022
Mammalian CDC14 phosphatases control exit from stemness in pluripotent cells
Carolina Villarroya-Beltri, Ana Filipa B Martins, Alejandro García, et al.
Oncogene
|
February 12, 2019
Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma
Irene Vázquez-Domínguez, Laura González-Sánchez, Pilar López-Nieva, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
Transient CB2 receptor activation triggers irreversible luminal differentiation via chromatin remodeling in breast cancer
Nuria G Martínez-Illescas, Gemma Pérez-García, María Rubert-Hernández, et al.
Breast Cancer Research : BCR
|
August 4, 2023
miR-203 drives breast cancer cell differentiation
Nuria G Martínez-Illescas, Silvia Leal, Patricia González, et al.
The EMBO Journal
|
July 3, 2020
Transient exposure to miR-203 enhances the differentiation capacity of established pluripotent stem cells
María Salazar-Roa, Marianna Trakala, Mónica Álvarez-Fernández, et al.
Autophagy
|
September 17, 2016
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
Sonia Hernández-Tiedra, Gemma Fabriàs, David Dávila, et al.
Oncogene
|
May 11, 2026
Cannabinoid CB<sub>2</sub> receptor drives trastuzumab resistance and predicts durable anti-HER2 response
Marta Seijo-Vila, Sofía A Balsinde, Sandra Blasco-Benito, et al.
Page
of 3